Meta-analysis: Nonsteroidal anti-inflammatory drugs in biliary colic

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 12, 2012, Pages 1370-1378

  Colli, A ^a   Conte, D ^b   Valle, S Della ^b   Sciola, V ^c   Fraquelli, M ^b  

^a A MANZONI HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c S Giuseppe Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; FLURBIPROFEN; GLUCAGON; KETOPROFEN; KETOROLAC; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PAPAVERINE; PENTAZOCINE; PETHIDINE; PLACEBO; SCOPOLAMINE; SPASMOLYTIC AGENT; TENOXICAM;

ABSENCE OF SIDE EFFECTS; ACUTE CHOLECYSTITIS; ANALGESIA; BILIARY COLIC; BLOOD PRESSURE; CHOLECYSTECTOMY; CHOLECYSTITIS; CHOLELITHIASIS; DIZZINESS; DROWSINESS; DRUG CHOICE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; META ANALYSIS; NAUSEA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTLESSNESS; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SIDE EFFECT; SYSTEMATIC REVIEW; TACHYCARDIA; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BILIARY TRACT DISEASES; COLIC; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 84861200353     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05115.x     Document Type: Review

References (36)

1. Angelico F, Del Ben M, Barbato A, Conti R, Urbinati G,. Ten-year incidence and natural history of gallstone disease in a rural population of women in central Italy. The Rome Group for the Epidemiology and Prevention of Cholelitiasis (GREPCO). Ital J Gastroenterol Hepatol 1997; 29: 249-54. (Pubitemid 28058781)
2. Gupta SK, Shukla VK,. Silent gallstones: a therapeutic dilemma. Trop Gastroenterol 2004; 25: 65-8.
3. Schirmer BD, Winters KL, Edlich RF,. Cholelithiasis and cholecystitis. J Long Term Eff Med Implants 2005; 13: 329-38. (Pubitemid 40826606)
4. Kimura Y, Takada T, Kawarada Y, et al,. Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007; 14: 15-26. (Pubitemid 46189138)
5. Attili AF, De Sanctis A, Capri R, Repice AM, Maselli S,. The natural history of gallstones: the GREPCO experience. the GREPCO Group. Hepatology 1995; 21: 655-60.
6. Thornell E, Jansson R, Svanvik J,. Indomethacin reduces raised intraluminal gallbladder pressure in acute cholecystitis. Acta Chir Scand 1985; 151: 261-5. (Pubitemid 15009508)
7. Kantor TG,. Use of diclofenac in analgesia. Am J Med 1986; 80: 64-9. (Pubitemid 16067996)
8. Brooks P,. Use and benefits of nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104: 9S-13S. (Pubitemid 28186988)
9. Morgan G,. Beneficial effects of NSAIDs in the gastrointestinal tract. Eur J Gastroenterol Hepatol 1999; 11: 393-400. (Pubitemid 29199839)
10. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C,. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials BMJ 2006; 332: 1302-8.
11. Basurto Ona X, Robles Perea L,. Antinflammatory drugs for biliary colics: a systematic revision and meta-analysis of clinical trials [Antinflammatorios para el colico biliar: revision sistematica y metanalisis de ensayos clinicos]. Gastroenterol Hepatol 2008; 31: 1-7.
12. Gluud C, Nikolova D, Klingenberg SL, Whitfield K, Alexakis N, Als-Nielsen B, Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2008, Issue 1. Art. No. Liver.
13. Royle P, Milne R,. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. Int J Technol Assess Health Care 2003; 19: 591-603. (Pubitemid 38405633)
14. Schulz KF, Chalmer I, Hayes RS, Altman DG,. Empirical evidence of bias: dimensions and methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-12.
15. Moher D, Pham B, Jones A, Cook DJ, et al,. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-13. (Pubitemid 28380142)
16. Kjaergard LL, Villumsen J, Gluud C,. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analysis. Ann Intern Med 2001; 135: 982-9. (Pubitemid 33131619)
17. Moher D, Liberati A, Tetzlaff J, Altman DG,. The PRISMA Group Preferred reporting items for Systematic reviews and meta.analyses. PloS Med 2009; 6: e1000097.
18. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: http://www.cochrane-handbook.org.
19. Review Manager (RevMan) 2008. [ Computer program ]. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
20. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88. (Pubitemid 17189972)
21. DeMets DL,. Methods for combining randomized clinical trials: strengths and limitations. Stat Med 1987; 6: 341-50.
22. Egger M, Smith GD, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34. (Pubitemid 27387172)
23. Akriviadis EA, Hatzigavriel M, Kapnias D, Kirimlidis J, Markantas A, Garyfallos A,. Treatment of biliary colic with diclofenac: a randomized, double-blind, placebo-controlled study. Gastroenterology 1997; 113: 225-31. (Pubitemid 27281778)
24. Al-Waili N, Saloom KY,. The analgesic effect of intravenous tenoxicam in symptomatic treatment of biliary colic: a comparison with hyoscine N-butylbromide. Eur J Med Res 1998; 3: 475-9.
25. Broggini M, Corbetta E, Grossi E, Borghi C,. Diclofenac sodium in biliary colic: a double blind trial. BMJ 1984; 288: 1042. (Pubitemid 14123596)
26. Camp Herrero J, Artigas Raventos V, Millà Santos J, Allende Honorato L, Dominguez Granados R, Moreno Carretero E,. Efficacy of injectable flurbiprofen in the symptomatic treatment of biliary colic [Eficacia del flurbiprofeno inyectable en el tratamiento sintomatico del colico biliar]. Med Clin (Barc) 1992; 98: 212-4.
27. Dula DJ, Anderson R, Wood GC,. A prospective study comparing i.m. ketorolac with i.m. meperidine in the treatment of acute biliary colic. J Emerg Med 2001; 20: 121-4. (Pubitemid 32149612)
28. Goldman G, Kahn PJ, Alon R, Wiznitzer T,. Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibitor. Dig Dis Sci 1989; 34: 809-11. (Pubitemid 19157833)
29. Grossi E, Broggini M, Quaranta M, Balestrino E,. Different pharmacological approaches to the treatment of acute biliary colic. Cur Ther Res 1986; 40: 876-82.
30. Henderson SO, Swadron S, Newton E,. Comparison of intravenous ketorolac and meperidine in the treatment of biliary colic. J Emerg Med 2002; 23: 237-41. (Pubitemid 35300243)
31. Lundstam S, Ivarsson L, Lindblad L, Kral JG,. Treatment of biliary pain by prostaglandin synthethase inhibition with diclofenac sodium. Curr Ther Res 1985; 37: 435-9. (Pubitemid 15141172)
32. Magrini M, Rivolta G, Movilia PG, Moretti MP, Liverta C, Bruni G,. Successful treatment of biliary colic with intravenous ketoprofen or lysine acetylsalicylate. Cur Med Res Opin 1985; 9: 454-60. (Pubitemid 15093439)
33. Kumar A, Deed JS, Bhasin B, Kumar A, Thomas S,. Comparison of the effect of diclofenac with hyoscine-N-butylbromide in the symptomatic treatment of acute biliary colic. J Surg 2004; 371: 435-9.
34. Elmunzer BJ, Waljee AK, Elta GH, Taylor JR, Fehmi SM, Higgins PD,. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 2008; 57: 1262-7.
35. Parkman HP, James AN, Thomas RM, Bartula LL, Ryan JP, Myers SI,. Effect of indomethacin on gallbladder inflammation and contractility during acute cholecystitis. J Surg Res 2001; 96: 135-42. (Pubitemid 34948247)
36. Pozo MJ, Camello PJ, Mawe GM,. Chemical mediators of gallbladder dysmotility. Curr Med Chem 2004; 11: 1801-12. (Pubitemid 38821345)